News

  • Radiomedix

    Macrocyclics produces cGMP peptide in support of NET clinical trial

    November 1, 2016

    Macrocyclics was contracted by Radiomedix and AREVA Med to produce the cGMP peptide conjugate that will be used in their collaborative clinical trial. RadioMedix and AREVA Med – SBIR NCI Contract awarded to develop targeted alpha-emitter therapy of neuroendocrine tumors with lead-212 Houston TX, Nov. 01, 2016 (GLOBE NEWSWIRE) — RadioMedix Inc. (Houston TX) and

    Read More